COMMODORE CAPITAL LP – CymaBay Therapeutics, Inc. Transaction History
COMMODORE CAPITAL LP portfolio value:
$20.08M
portfolio value
COMMODORE CAPITAL LP quarter portfolio value change:
+18.64%
quarter
CymaBay Therapeutics, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 3.15M | $3.5 | 5.73M | |
Q2 2022 | share | 0.00% | 0 shares | -918K | $2.95 | 5.73M | |
Q1 2022 | share | Increase | +5.88% | 318.60K shares | -472K | $3.11 | 5.73M |
Q4 2021 | share | Increase | +29.98% | 1.25M shares | 3.09M | $3.3 | 5.41M |
Q3 2021 | share | Increase | +18.15% | 640.43K shares | -168K | $3.65 | 4.16M |
Q2 2021 | share | Increase | +18.30% | 545.95K shares | 1.84M | $4.36 | 3.52M |
Q1 2021 | share | Increase | +100.76% | 1.49M shares | 5.01M | $4.54 | 2.98M |
Q4 2020 | share | Increase | 0.00% | 1.48M shares | 8.53M | $5.74 | 1.48M |